Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
about
Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapyUse of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with ventriculopleural shuntsEosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma.Off label and unlicensed drug use among French office based paediatriciansEosinophil activation and preschool viral wheezeGlucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.An update of the leukotriene modulators for the treatment of asthma.Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trialEfficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma.The clinical profile of benralizumab in the management of severe eosinophilic asthma.The clinical course of childhood asthma in association with fever.Detection of R576 interleukin-4 receptor an allele gene, serum interleukin-4, and eosinophilic cationic protein in atopic dermatitis patients.Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma.A canine model of cutaneous late-phase reactions: prednisolone inhibition of cellular and cytokine responses.Serum interleukin-5 measurements for monitoring acute asthma in children.
P2860
Q24806249-B47684AB-703B-4E6C-8EA1-9912D59FA84FQ28345292-6DEEB104-7C43-4AC0-9286-6D275732B2FEQ35197020-F556E2F6-691E-486C-BC4D-D8E1AFBF444CQ35268405-AA7A6851-863B-4387-8567-5B111B442D7AQ35535512-EEBC4893-30BA-4CE8-A62A-88CCDC1AA09CQ35742927-0D00D166-F4D9-4105-9EDD-206B94EFB1D7Q35814442-D7DEADC4-A62D-43A2-B9AE-D59DE6D6FCF0Q36351758-A54CB3D9-C8A9-4D91-B156-F767423364DBQ38818964-BB397705-2453-47B2-9775-E7EB4C696B9BQ38822826-7D8C4CBE-B16E-4A1A-B1E5-D887ADAF9DF1Q40390815-47D385DF-AC56-4E76-AEC1-D677E8F95D39Q42944259-618274A7-9EE3-4944-B0C5-7DCCA2429C03Q44173555-926725F9-B8C6-4D6A-9F5F-3BC4C154965CQ44864686-F93D05AD-4CEF-4384-8C85-194088BC2FC6Q46609922-B1C399CD-9A1C-4F01-AB81-2BA23B73A4CD
P2860
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
@ast
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
@en
type
label
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
@ast
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
@en
prefLabel
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
@ast
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
@en
P2093
P2860
P356
P1476
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.
@en
P2093
Corrigan CJ
Sahid El-Radhi A
P2860
P304
P356
10.1136/ADC.83.2.158
P407
P577
2000-08-01T00:00:00Z